Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 15889282)

Published in Pediatr Nephrol on May 12, 2005

Authors

Karsten Häffner1, Lothar B Zimmerhackl, Christian von Schnakenburg, Matthias Brandis, Martin Pohl

Author Affiliations

1: Department of Pediatrics and Adolescent Medicine, Albert-Ludwigs-University, Mathildenstrasse 1, 79106 Freiburg, Germany.

Articles cited by this

Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int (1999) 2.30

A glomerular permeability factor produced by human T cell hybridomas. Kidney Int (1991) 1.61

Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol (1992) 1.34

Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med (1992) 1.24

Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol (2001) 1.18

Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis (2003) 1.13

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis (1999) 1.09

Renal transplantation in children and adolescents: the 1992 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol (1993) 1.07

Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation (2003) 1.02

Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol (1993) 0.99

Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int (1994) 0.92

Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol (2003) 0.87

Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis. Transplantation (1996) 0.80

Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol (2000) 0.78

Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation. J Clin Apher (2002) 0.77

The different patterns of response to plasmapheresis of recurrent focal and segmental glomerulosclerosis. Transplant Proc (2002) 0.77

Recurrence of primary renal disease on kidney graft: a European pediatric experience. J Am Soc Nephrol (1992) 0.76

Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation. Ann Med Interne (Paris) (1992) 0.76

Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies. J Am Soc Nephrol (1999) 0.75

Management of recurrent nephrotic syndrome after kidney transplantation in children. Clin Nephrol (1996) 0.75

[Value of cyclosporine in the treatment of the recurrence of nephrosis after renal transplantation]. Nephrologie (1996) 0.75

Articles by these authors

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet (2006) 5.29

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis (2002) 2.89

Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis (2005) 2.50

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol (2008) 2.30

Nephrocystin specifically localizes to the transition zone of renal and respiratory cilia and photoreceptor connecting cilia. J Am Soc Nephrol (2006) 1.79

An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis (2012) 1.79

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One (2007) 1.73

Takayasu arteritis in children and adolescents. Rheumatology (Oxford) (2010) 1.58

Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials (2006) 1.38

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38

Differential expression of collagen- and laminin-binding integrins mediates ureteric bud and inner medullary collecting duct cell tubulogenesis. Am J Physiol Renal Physiol (2004) 1.34

ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet (2013) 1.32

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol (2009) 1.29

Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol (2004) 1.28

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant (2011) 1.24

Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency. Ann Neurol (2002) 1.15

CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. J Clin Oncol (2007) 1.10

Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia. Pediatr Res (2003) 1.09

SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome. J Med Genet (2007) 1.08

A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clin J Am Soc Nephrol (2009) 1.07

Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis (2003) 1.07

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. J Am Soc Nephrol (2011) 1.06

Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatr Nephrol (2003) 1.06

CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology (2004) 1.04

Missense mutations in EYA1 and TCF2 are a rare cause of urinary tract malformations. Nephrol Dial Transplant (2007) 1.00

Biocompatibility of corroding tungsten coils: in vitro assessment of degradation kinetics and cytotoxicity on human cells. Biomaterials (2003) 1.00

Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation. Nephrol Dial Transplant (2009) 0.99

Primary hyperoxaluria--the German experience. Am J Nephrol (2005) 0.96

Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children. Pediatr Res (2002) 0.95

Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype. Mol Genet Metab (2011) 0.93

Identification of a gene locus for Senior-Løken syndrome in the region of the nephronophthisis type 3 gene. J Am Soc Nephrol (2002) 0.93

Fungal alternative splicing is associated with multicellular complexity and virulence: a genome-wide multi-species study. DNA Res (2013) 0.89

Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr Res (2002) 0.88

Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Eur J Hum Genet (2012) 0.88

Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil. Transplantation (2009) 0.87

Teratocarcinosarcoma of the oral cavity. Pediatr Blood Cancer (2004) 0.87

Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation. Pediatr Transplant (2005) 0.86

Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis. Pediatr Nephrol (2002) 0.86

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation. Transpl Int (2012) 0.86

Confirmation of the ATP6B1 gene as responsible for distal renal tubular acidosis. Pediatr Nephrol (2002) 0.85

Ulceroglandular tularemia in a toddler in Germany after a mosquito bite. Eur J Pediatr (2009) 0.85

Nephrocystin and ciliary defects not only in the kidney? Pediatr Nephrol (2007) 0.84

Benign course of central pontine myelinolysis in a patient with anorexia nervosa. Pediatr Neurol (2002) 0.84

Mutations in WDR19 encoding the intraflagellar transport component IFT144 cause a broad spectrum of ciliopathies. Pediatr Nephrol (2014) 0.83

New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin Thromb Hemost (2006) 0.83

Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Transplantation (2003) 0.83

Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young (2002) 0.83

Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr (2005) 0.82

Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants. Pediatr Int (2009) 0.82

Polymorphisms in the cell wall-spanning domain of the C protein beta-antigen in clinical Streptococcus agalactiae isolates are caused by genetic instability of repeating DNA sequences. Pediatr Res (2002) 0.82

Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study. Clin Infect Dis (2012) 0.82

Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches. Nat Rev Nephrol (2010) 0.81

Fanconi-Bickel syndrome and fertility. Am J Med Genet A (2011) 0.80

A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Pediatr Res (2003) 0.80

Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection. Ther Drug Monit (2004) 0.80

Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transplant (2008) 0.79

Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation. Transplantation (2007) 0.79

Assessment of subacute inflammatory and proliferative response to coronary stenting in a porcine model by local gene expression studies and histomorphometry. Biomaterials (2004) 0.79

Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Clin Chem (2002) 0.79

Kidney transplantation with concomitant unilateral nephrectomy: a matched-pair analysis on complications and outcome. Transplantation (2006) 0.78

Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation (2008) 0.78

Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation (2008) 0.77

D-lactic acidosis: "right-left disorientation" in laboratory testing: acute encephalopathy in a child with carbohydrate malabsorption syndrome. J Pediatr Gastroenterol Nutr (2010) 0.76

L1CAM mutation in a boy with hydrocephalus and duplex kidneys. Pediatr Nephrol (2007) 0.76

Successful extracorporeal treatment of a male with hyperammonaemic coma. Nephrol Dial Transplant (2005) 0.75

Note of caution for the use of sodium nitroprusside in neonatal hypertension. Pediatr Nephrol (2004) 0.75

Genetic analysis: a diagnostic tool for primary hyperoxaluria type 1. Pediatr Nephrol (2003) 0.75

Autonomous thyroid adenoma: only an adulthood disease? J Pediatr (2009) 0.75

EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease. Transplantation (2013) 0.75

Transitional Care and Adherence of Adolescents and Young Adults After Kidney Transplantation in Germany and Austria: A Binational Observatory Census Within the TRANSNephro Trial. Medicine (Baltimore) (2015) 0.75

Increased incidence of adenoidectomy and tonsillectomy in children with renal transplantation. Pediatr Nephrol (2014) 0.75

Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir. Transplantation (2016) 0.75

Clinical quiz. Diagnosis: Langerhans' cell histiocytosis (LCH). J Pediatr Gastroenterol Nutr (2006) 0.75

Criteria for solid recovered fuels as a substitute for fossil fuels--a review. Waste Manag Res (2012) 0.75

Composition and in vitro biocompatibility of corroding tungsten coils. J Biomed Mater Res B Appl Biomater (2003) 0.75

Histopathological follow-up after bailout stenting for early postoperative stenosis of a central aorto-pulmonary shunt. Cardiol Young (2003) 0.75

Pressure support ventilation combined with volume guarantee versus synchronized intermittent mandatory ventilation: a pilot crossover trial in premature infants in their weaning phase. Pediatr Crit Care Med (2005) 0.75

Living-donor kidney transplantation: the Freiburg experience. Langenbecks Arch Surg (2006) 0.75

Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome? J Trop Pediatr (2013) 0.75

Presentation of the 2001 Jean Hamburger Award to Professor Anita Aperia. Kidney Int (2003) 0.75

Dielectric discontinuity effects on the adsorption of a linear polyelectrolyte at the surface of a neutral nanoparticle. J Chem Phys (2009) 0.75